Intelence

Etravirine, the active ingredient in Intelence, is a Non‑nucleoside reverse transcriptase inhibitor (NNRTI) presented as a tablet for oral use. It is indicated for the treatment of HIV‑1 infection in combination with other antiretroviral agents, helping to suppress viral replication in adults and adolescents.

GNH USA supplies Intelence as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Intelence (etravirine) is used in the management of HIV‑1 infection, a viral disease treated with antiretroviral therapy.

- HIV‑1 infection: used in combination with other antiretroviral agents to achieve viral suppression.

Adverse reactions may occur with Intelence and should be monitored.

Common Side Effects: - Rash: mild to moderate skin eruptions. - Nausea: occasional upset stomach. - Headache: transient head discomfort. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Hepatic failure: signs of liver dysfunction. - Severe hypersensitivity: including anaphylaxis. - Pancreatitis: inflammation of the pancreas. - Severe depression or suicidal thoughts.

Before initiating Intelence, certain precautions are recommended.

- Assess hepatic function: evaluate liver enzymes prior to therapy. - Monitor for rash: watch for skin changes and report promptly. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Review concomitant medications: check for potential drug interactions. - Store at room temperature: keep in the original pack, protect from moisture.

Intelence may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Ritonavir‑boosted protease inhibitors: may increase etravirine levels. - Efavirenz: can reduce etravirine efficacy. - Nevirapine: may lead to reduced therapeutic effect.

Moderate Interactions (Monitor Closely): - St. John’s wort: may decrease plasma concentrations. - Antacids containing aluminum or magnesium: can affect absorption. - Warfarin: monitor INR for potential anticoagulant effect changes.